Company Filing History:
Years Active: 1977
Title: David Henry Tedeschi: Innovator in Pharmaceutical Formulations
Introduction
David Henry Tedeschi is a notable inventor based in Little Falls, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work has implications for the effective delivery of medications, enhancing patient care and treatment outcomes.
Latest Patents
Tedeschi holds a patent for "Sustained release forms of certain oxazepines for parenteral." This patent describes a sustained release depot form of the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]-oxazepine or 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f]-[1,4]oxazepine in an injectable oil for parenteral administration. This innovation is crucial for improving the delivery and efficacy of certain medications.
Career Highlights
Tedeschi has been associated with the American Cyanamid Company, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Tedeschi has worked alongside notable colleagues such as George Madison Sieger and James Elwood Krueger. These collaborations have fostered innovation and advancements in pharmaceutical sciences.
Conclusion
David Henry Tedeschi's contributions to the field of pharmaceuticals through his patent and work at American Cyanamid Company highlight his role as an innovator. His sustained release formulations represent a significant advancement in medication delivery systems.